LORI A. FANNING has 23 years of legal experience and concentrates her practice on complex class litigation in a wide range of matters in federal and state court, primarily in the areas of antitrust, consumer protection, derivatives, and securities. She has prosecuted a variety of lawsuits involving the airline, banking, credit card, internet, and pharmaceutical industries. Ms. Fanning currently litigates antitrust claims in the pharmaceutical sector, primarily on behalf of union health and welfare funds, including such cases as Actos, Effexor, Namenda (as co-lead counsel for the Indirect Purchaser Class) Niaspan, Suboxone, and Zetia, and previously in such actions as Aggrenox, Loestrin, and Solodyn. Ms. Fanning was also co-lead counsel for the End Payor Class in Flonase . She has also prosecuted actions such as In re: Polyurethane Antitrust Litigation which settled for over $150 million; consumer protection actions, such as Greene v. Sears Protection Company, et al., 15-cv-2546 (N.D. Ill.) where a nationwide class was certified and she has defended patent litigation on behalf of Datamation Systems, Inc. Ms. Fanning actively participated in the trial preparations for In re Visa Check/MasterMoney Antitrust Litigation, a civil antitrust case that settled for in excess of $3 billion on the eve of trial.